American Bio Medica Corporation
ABMCOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$4810
P/E Ratio—
52W High$0.0002
52W Low$0.0001
American Bio Medica Corporation (ABMC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ABMC · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2023Report Date: Jun 12, 2023EPS Actual
$0.08
Revenue
$0.00B
Fiscal Period
Q2 FY2023
FY ends December
Report Date
Jun 12, 2023
After Market Close
ABMC reports quarterly as a OTC-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2023 | Jun 12, 2023 | — | $0.08 | — | $0.00B | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2022 | Nov 16, 2022 | — | -$0.01 | — | $0.00B | — | — |
| — Q3 FY2022 | Aug 15, 2022 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2022 | May 16, 2022 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2021 | Dec 31, 2021 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2021 | Nov 18, 2021 | — | $0.02 | — | $0.00B | — | — |
| — Q3 FY2021 | Aug 18, 2021 | — | -$0.01 | — | $0.00B | — | — |
Q2 FY2023
Jun 12, 2023
EPS Actual
$0.08
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Nov 16, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Aug 15, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2022
May 16, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2021
Dec 31, 2021
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2021
Nov 18, 2021
EPS Actual
$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2021
Aug 18, 2021
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2023 | Jun 12, 2023 | — | $0.01 | $0.01 | +54.67% |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.01 | $0.01 | +0.00% |
| — Q4 FY2022 | Nov 16, 2022 | — | $0.02 | $0.02 | -2.96% |
| — Q3 FY2022 | Aug 15, 2022 | — | $0.03 | $0.02 | -27.80% |
| — Q2 FY2022 | May 16, 2022 | — | $0.02 | $0.02 | +12.50% |
| — Q4 FY2021 | Dec 31, 2021 | — | $0.03 | $0.04 | +25.00% |
| — Q4 FY2021 | Nov 18, 2021 | — | $0.05 | $0.04 | -2.39% |
| — Q3 FY2021 | Aug 18, 2021 | — | $0.05 | $0.04 | -25.00% |
Q2 FY2023+54.67%
Report Date
Jun 12, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2022-2.96%
Report Date
Nov 16, 2022
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q3 FY2022-27.80%
Report Date
Aug 15, 2022
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.02
Q2 FY2022+12.50%
Report Date
May 16, 2022
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q4 FY2021+25.00%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.04
Q4 FY2021-2.39%
Report Date
Nov 18, 2021
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.04
Q3 FY2021-25.00%
Report Date
Aug 18, 2021
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.04
Beat Rate0 / 8 quarters
Largest Move+54.67% (Q2 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ABMC ends December
American Bio Medica Corporation (ABMC) most recently reported earnings on June 12, 2023 for Q2 FY2023, posting EPS of $0.08 (in line with the analyst consensus of —). The next ABMC earnings date is expected around September 1, 2026.
Each quarter, investors track ABMC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ABMC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ABMC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ABMC earnings · 4 questionsAmerican Bio Medica Corporation's next earnings report is expected around September 1, 2026. ABMC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ABMC historically reports after market close (AMC).
ABMC earnings datewhen is ABMC earningsABMC next earnings datewhen does ABMC report earningsABMC earnings calendar
▸ Source: FMP · American Bio Medica Corporation SEC filings · US GAAP · American Bio Medica Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026